12-111456268-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001372574.1(ATXN2):c.3043-12G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.208 in 1,613,538 control chromosomes in the GnomAD database, including 36,117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.20 ( 3228 hom., cov: 33)
Exomes 𝑓: 0.21 ( 32889 hom. )
Consequence
ATXN2
NM_001372574.1 intron
NM_001372574.1 intron
Scores
2
Splicing: ADA: 0.00002213
2
Clinical Significance
Conservation
PhyloP100: -1.76
Publications
22 publications found
Genes affected
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
ATXN2 Gene-Disease associations (from GenCC):
- spinocerebellar ataxia type 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-111456268-C-T is Benign according to our data. Variant chr12-111456268-C-T is described in ClinVar as Benign. ClinVar VariationId is 522365.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATXN2 | NM_001372574.1 | c.3043-12G>A | intron_variant | Intron 22 of 24 | ENST00000673436.1 | NP_001359503.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATXN2 | ENST00000673436.1 | c.3043-12G>A | intron_variant | Intron 22 of 24 | NM_001372574.1 | ENSP00000500925.1 |
Frequencies
GnomAD3 genomes AF: 0.202 AC: 30760AN: 151972Hom.: 3227 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
30760
AN:
151972
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.210 AC: 52837AN: 251260 AF XY: 0.213 show subpopulations
GnomAD2 exomes
AF:
AC:
52837
AN:
251260
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.209 AC: 305612AN: 1461446Hom.: 32889 Cov.: 32 AF XY: 0.210 AC XY: 152638AN XY: 726990 show subpopulations
GnomAD4 exome
AF:
AC:
305612
AN:
1461446
Hom.:
Cov.:
32
AF XY:
AC XY:
152638
AN XY:
726990
show subpopulations
African (AFR)
AF:
AC:
6321
AN:
33470
American (AMR)
AF:
AC:
7316
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
2859
AN:
26134
East Asian (EAS)
AF:
AC:
11075
AN:
39692
South Asian (SAS)
AF:
AC:
23576
AN:
86248
European-Finnish (FIN)
AF:
AC:
10080
AN:
53406
Middle Eastern (MID)
AF:
AC:
1883
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
229474
AN:
1111626
Other (OTH)
AF:
AC:
13028
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
14549
29098
43648
58197
72746
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8018
16036
24054
32072
40090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.202 AC: 30771AN: 152092Hom.: 3228 Cov.: 33 AF XY: 0.201 AC XY: 14950AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
30771
AN:
152092
Hom.:
Cov.:
33
AF XY:
AC XY:
14950
AN XY:
74362
show subpopulations
African (AFR)
AF:
AC:
8047
AN:
41460
American (AMR)
AF:
AC:
2704
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
379
AN:
3470
East Asian (EAS)
AF:
AC:
1712
AN:
5176
South Asian (SAS)
AF:
AC:
1287
AN:
4822
European-Finnish (FIN)
AF:
AC:
1957
AN:
10582
Middle Eastern (MID)
AF:
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14008
AN:
67978
Other (OTH)
AF:
AC:
450
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1259
2518
3776
5035
6294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1041
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Spinocerebellar ataxia type 2 Benign:1
Oct 05, 2015
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.